Etienne Régulier, based in Basel, BS, CH, is currently a Global Head of Patient Access Cell and Gene Therapy at Santen, bringing experience from previous roles at Santen, Roche, Actelion (now Janssen Pulmonary Hypertension) and Strategic Access Solutions Ltd - Stratas Partners. Etienne Régulier holds a 2001 - 2005 Post-Doc in Neurogenomics and Neurobiology in In vitro and in vivo modelisation of neurodegenerative diseases using lentiviral vectors @ EPFL (École polytechnique fédérale de Lausanne). With a robust skill set that includes Pricing Strategy, Funding, Life Cycle Assessment, Analysis, Portfolio Management and more, Etienne Régulier contributes valuable insights to the industry. Etienne Régulier has 1 email and 1 mobile phone number on RocketReach.